Video

Dr. VanderWalde on Future Research in Rectal Cancer

Noam VanderWalde, MD, MS, discusses ​where future research ​efforts should focus in rectal cancer. 

Noam VanderWalde, MD, MS, associate professor of radiation oncology, West Cancer Center and Research Institute, discusses ​where future research ​efforts should focus in rectal cancer. 

Treatment personalization in terms of medical management, patient preference, and health-related quality of life, needs to be further evaluated, says VanderWalde. 

Moreover, factors that influence decision making should be assessed, VanderWalde explains.

Typically, surgical eligibility based on results from physical exams and and MRI; however, circulating tumor DNA may provide better insight ​on whether a patient should undergo surgery, VanderWalde concludes.

Related Videos
James J. Harding, MD, associate attending physician, Memorial Sloan Kettering Cancer Center
J. Bradley Elder, MD
Rimas V. Lukas, MD
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Shubham Pant, MD, MBBS
Kevin Kalinsky, MD, MS, professor, Department of Hematology and Medical Oncology, director, Division of Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine; Louisa and Rand Glenn Family Chair in Breast Cancer Research, director, Glenn Family Breast Center, director, Breast Medical Oncology, Winship Cancer Institute of Emory University
Brett L. Ecker, MD
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center